› Forums › General Melanoma Community › Unraveling the mysteries of drug resistance in melanoma with CRISPR-Cas9
- This topic has 1 reply, 1 voice, and was last updated 6 years, 4 months ago by ed williams.
- Post
-
- August 24, 2018 at 3:45 pm
Viewing 0 reply threads
- Replies
-
-
- August 24, 2018 at 5:57 pm
Hi Anon, this topic has come up before of Gene editing "Crispr-cas9" and now new "cas12a' but not close to being ready for prime time. If i understand the problems that they are facing is getting the target and not editing random genes that are health which could cause all kinds of problems. Here is another link to piercebiotech article, the one above didn't work for me!!! https://www.fiercebiotech.com/biotech/a-better-enzyme-for-crispr-gene-editing
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.